SERA
Sera Prognostics
Stock NASDAQ – Stock Market Prices, News & Analysis
Sera Prognostics develops diagnostic tests that assess risks for pregnant women and their babies, enabling better clinical decision-making.
Sera Prognostics
SERA
Sera Prognostics develops diagnostic tests that assess risks for pregnant women and their babies, enabling better clinical decision-making.
Price history of Sera Prognostics
Price history of Sera Prognostics
Performance & Momentum
Strategic Analysis
Sera Prognostics • 2026
Sera Prognostics positions itself as a specialized player in prenatal diagnostics, developing innovative tests aimed at assessing risks during pregnancy. Its model relies on clinical precision to improve medical decision-making, targeting a critical niche within maternal and infant health.
- Innovative diagnostic approach focused on high-risk pregnancy
- Growth potential in a high-value medical segment
- Technological expertise promoting better clinical management
- Very negative long-term stock performance history
- Current lack of visible catalysts and high volatility
Recent momentum is weak and negative, reflecting a significant decline in the stock price despite a niche positioning. This trend likely indicates operational or market challenges, urging increased caution before any investment decisions.
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
